Biolase Shares Jump on FDA, European Approvals

Shares of Irvine-based dental laser maker Biolase Technology Inc. jumped in early trading today on word that the Food and Drug Administration and European regulators approved a new device.

Biolase shares were up 34% in midday trading today to a market value of about $72 million.

The company said in a news release that it received FDA approval for its Epic 10 laser and immediately began selling it in the U.S.

Biolase added that Epic 10, which is used in soft tissue dental surgery and other procedures, also received European regulatory approval and is now sold in Europe and some Asian and Latin American countries.